Sarissa Capital Management LP - ARRAY BIOPHARMA INC ownership

Back to all holdings Add to watchlist

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 154 filers reported holding ARRAY BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Sarissa Capital Management LP ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q3 2016$29,025,000
+89.6%
4,300,0000.0%6.68%
+53.8%
Q2 2016$15,308,000
+80.5%
4,300,000
+49.6%
4.34%
+132.5%
Q1 2016$8,481,000
+187.1%
2,875,000
+310.7%
1.87%
+225.6%
Q4 2015$2,954,000–700,000–0.57%–
 Download
Other shareholders

There were no reported owners of ARRAY BIOPHARMA INC in Q4 2015.

NameSharesValueWeighting ↓
View complete list of ARRAY BIOPHARMA INC shareholders